246 related articles for article (PubMed ID: 28614215)
1. Effects of branched-chain amino acids (BCAAs) on the progression of advanced liver disease: A Korean nationwide, multicenter, retrospective, observational, cohort study.
Park JG; Tak WY; Park SY; Kweon YO; Jang SY; Lee YR; Bae SH; Jang JY; Kim DY; Lee JS; Suk KT; Kim IH; Lee HJ; Chung WJ; Jang BK; Suh JI; Heo J; Lee WK
Medicine (Baltimore); 2017 Jun; 96(24):e6580. PubMed ID: 28614215
[TBL] [Abstract][Full Text] [Related]
2. Effects of Branched-Chain Amino Acid (BCAA) Supplementation on the Progression of Advanced Liver Disease: A Korean Nationwide, Multicenter, Prospective, Observational, Cohort Study.
Park JG; Tak WY; Park SY; Kweon YO; Chung WJ; Jang BK; Bae SH; Lee HJ; Jang JY; Suk KT; Oh MJ; Heo J; Woo HY; Jang SY; Lee YR; Lee JS; Kim DY; Kim SH; Suh JI; Kim IH; Kang MK; Lee WK
Nutrients; 2020 May; 12(5):. PubMed ID: 32429077
[TBL] [Abstract][Full Text] [Related]
3. Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis.
Hayaishi S; Chung H; Kudo M; Ishikawa E; Takita M; Ueda T; Kitai S; Inoue T; Yada N; Hagiwara S; Minami Y; Ueshima K
Dig Dis; 2011; 29(3):326-32. PubMed ID: 21829025
[TBL] [Abstract][Full Text] [Related]
4. Branched-chain amino acids prevent hepatocarcinogenesis and prolong survival of patients with cirrhosis.
Kawaguchi T; Shiraishi K; Ito T; Suzuki K; Koreeda C; Ohtake T; Iwasa M; Tokumoto Y; Endo R; Kawamura NH; Shiraki M; Habu D; Tsuruta S; Miwa Y; Kawaguchi A; Kakuma T; Sakai H; Kawada N; Hanai T; Takahashi S; Kato A; Onji M; Takei Y; Kohgo Y; Seki T; Tamano M; Katayama K; Mine T; Sata M; Moriwaki H; Suzuki K
Clin Gastroenterol Hepatol; 2014 Jun; 12(6):1012-8.e1. PubMed ID: 24036055
[TBL] [Abstract][Full Text] [Related]
5. A randomized pilot trial of oral branched-chain amino acids in early cirrhosis: validation using prognostic markers for pre-liver transplant status.
Kawamura E; Habu D; Morikawa H; Enomoto M; Kawabe J; Tamori A; Sakaguchi H; Saeki S; Kawada N; Shiomi S
Liver Transpl; 2009 Jul; 15(7):790-7. PubMed ID: 19562716
[TBL] [Abstract][Full Text] [Related]
6. Importance of branched-chain amino acids in patients with liver cirrhosis and advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
Kanekawa T; Nagai H; Kanayama M; Sumino Y
Cancer Chemother Pharmacol; 2014 Nov; 74(5):899-909. PubMed ID: 25138286
[TBL] [Abstract][Full Text] [Related]
7. Late evening snacks with branched-chain amino acids improve the Fischer ratio with patients liver cirrhosis at fasting in the next morning.
Maki H; Yamanaka-Okumura H; Katayama T; Ozawa Y; Hosoda A; Kurata N; Amemiya F
Clin Nutr ESPEN; 2019 Apr; 30():138-144. PubMed ID: 30904214
[TBL] [Abstract][Full Text] [Related]
8. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis.
Muto Y; Sato S; Watanabe A; Moriwaki H; Suzuki K; Kato A; Kato M; Nakamura T; Higuchi K; Nishiguchi S; Kumada H;
Clin Gastroenterol Hepatol; 2005 Jul; 3(7):705-13. PubMed ID: 16206505
[TBL] [Abstract][Full Text] [Related]
9. Effect of a high-protein, high-fiber diet plus supplementation with branched-chain amino acids on the nutritional status of patients with cirrhosis.
Ruiz-Margáin A; Macías-Rodríguez RU; Ríos-Torres SL; Román-Calleja BM; Méndez-Guerrero O; Rodríguez-Córdova P; Torre A
Rev Gastroenterol Mex (Engl Ed); 2018; 83(1):9-15. PubMed ID: 28408059
[TBL] [Abstract][Full Text] [Related]
10. A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma.
Takeshita S; Ichikawa T; Nakao K; Miyaaki H; Shibata H; Matsuzaki T; Muraoka T; Honda T; Otani M; Akiyama M; Miuma S; Ozawa E; Fujimito M; Eguchi K
Nutr Res; 2009 Feb; 29(2):89-93. PubMed ID: 19285598
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of branched-chain amino acid granules on progression of compensated liver cirrhosis due to hepatitis C virus.
Kobayashi M; Ikeda K; Arase Y; Suzuki Y; Suzuki F; Akuta N; Hosaka T; Murashima N; Saitoh S; Someya T; Tsubota A; Kumada H
J Gastroenterol; 2008; 43(1):63-70. PubMed ID: 18297438
[TBL] [Abstract][Full Text] [Related]
12. Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study.
Les I; Doval E; García-Martínez R; Planas M; Cárdenas G; Gómez P; Flavià M; Jacas C; Mínguez B; Vergara M; Soriano G; Vila C; Esteban R; Córdoba J
Am J Gastroenterol; 2011 Jun; 106(6):1081-8. PubMed ID: 21326220
[TBL] [Abstract][Full Text] [Related]
13. Effect of branched-chain amino acids in patients receiving intervention for hepatocellular carcinoma.
Ishihara T; Iwasa M; Tanaka H; Kaito M; Ikoma J; Shibata T; Takei Y
World J Gastroenterol; 2014 Mar; 20(10):2673-80. PubMed ID: 24627603
[TBL] [Abstract][Full Text] [Related]
14. Branched-chain amino acid enriched supplements as therapy for liver disease.
Charlton M
J Nutr; 2006 Jan; 136(1 Suppl):295S-8S. PubMed ID: 16365102
[TBL] [Abstract][Full Text] [Related]
15. Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis.
Kawaguchi T; Taniguchi E; Sata M
Nutr Clin Pract; 2013 Oct; 28(5):580-8. PubMed ID: 23945292
[TBL] [Abstract][Full Text] [Related]
16. Branched-chain amino acids as pharmacological nutrients in chronic liver disease.
Kawaguchi T; Izumi N; Charlton MR; Sata M
Hepatology; 2011 Sep; 54(3):1063-70. PubMed ID: 21563202
[TBL] [Abstract][Full Text] [Related]
17. Effect of branched-chain amino acid supplementation and exercise on quadriceps muscle quantity and quality in patients with cirrhosis as assessed by ultrasonography: A randomized controlled trial.
Sobhy E; Kamal MM; Saad Y; Saleh DA; Elgohary R; Hassan MS
Clin Nutr ESPEN; 2024 Jun; 61():108-118. PubMed ID: 38777422
[TBL] [Abstract][Full Text] [Related]
18. Branched-chain amino acids supplementation improves liver frailty index in frail compensated cirrhotic patients: a randomized controlled trial.
Siramolpiwat S; Limthanetkul N; Pornthisarn B; Vilaichone RK; Chonprasertsuk S; Bhanthumkomol P; Nunanan P; Issariyakulkarn N
BMC Gastroenterol; 2023 May; 23(1):154. PubMed ID: 37189033
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of early interventional therapy of branched-chain amino acid granules in patients with hepatocellular carcinoma: propensity score matching analysis.
Nishikawa H; Kita R; Kimura T; Ohara Y; Takeda H; Sakamoto A; Saito S; Nishijima N; Nasu A; Komekado H; Osaki Y
Int J Oncol; 2014 Sep; 45(3):1082-90. PubMed ID: 24969042
[TBL] [Abstract][Full Text] [Related]
20. Effects of branched-chain amino acid supplementation after radiofrequency ablation for hepatocellular carcinoma: A randomized trial.
Nojiri S; Fujiwara K; Shinkai N; Iio E; Joh T
Nutrition; 2017 Jan; 33():20-27. PubMed ID: 27908546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
